Kyntra Bio, Inc. Common Stock (KYNB) is a publicly traded the market company. As of August 6, 2026, KYNB trades at $6.99 with a market cap of $28.01M and a P/E ratio of 0.00. KYNB moved +0.00% today. Year to date, KYNB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $6.32 to $9.70. Analyst consensus is strong buy with an average price target of $36.00. Rallies surfaces KYNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kyntra Bio, Inc. Common Stock (KYNB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KYNB moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $6.99 |
| Market Cap | $28.01M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.70 |
| 52-Week Low | $6.32 |
| Volume | 363 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover KYNB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $36.00.